AT376426B - Verfahren zum herstellen neuer derivate der 2-hydroxy-5-(1-hydroxy-2-piperazinylaethyl)benzoes[ure und saeureadditionssalzen hievon - Google Patents

Verfahren zum herstellen neuer derivate der 2-hydroxy-5-(1-hydroxy-2-piperazinylaethyl)benzoes[ure und saeureadditionssalzen hievon

Info

Publication number
AT376426B
AT376426B AT0232580A AT232580A AT376426B AT 376426 B AT376426 B AT 376426B AT 0232580 A AT0232580 A AT 0232580A AT 232580 A AT232580 A AT 232580A AT 376426 B AT376426 B AT 376426B
Authority
AT
Austria
Prior art keywords
hydroxy
piperazinylaethyl
hievon
benzoes
ure
Prior art date
Application number
AT0232580A
Other languages
German (de)
English (en)
Other versions
ATA232580A (de
Original Assignee
Richardson Merrell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Richardson Merrell Inc filed Critical Richardson Merrell Inc
Publication of ATA232580A publication Critical patent/ATA232580A/de
Application granted granted Critical
Publication of AT376426B publication Critical patent/AT376426B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D213/00Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72Nitrogen atoms
    • C07D213/74Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/14Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D295/155Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT0232580A 1979-05-04 1980-04-30 Verfahren zum herstellen neuer derivate der 2-hydroxy-5-(1-hydroxy-2-piperazinylaethyl)benzoes[ure und saeureadditionssalzen hievon AT376426B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/036,244 US4255575A (en) 1979-05-04 1979-05-04 2-Hydroxy-5-(1-hydroxy-2-piperazinylethyl)-benzoic acid derivatives

Publications (2)

Publication Number Publication Date
ATA232580A ATA232580A (de) 1984-04-15
AT376426B true AT376426B (de) 1984-11-26

Family

ID=21887503

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0232580A AT376426B (de) 1979-05-04 1980-04-30 Verfahren zum herstellen neuer derivate der 2-hydroxy-5-(1-hydroxy-2-piperazinylaethyl)benzoes[ure und saeureadditionssalzen hievon

Country Status (21)

Country Link
US (1) US4255575A (xx)
JP (1) JPS55147262A (xx)
AT (1) AT376426B (xx)
AU (1) AU531738B2 (xx)
BE (1) BE883086A (xx)
CA (1) CA1138457A (xx)
CH (1) CH645368A5 (xx)
DE (1) DE3014813A1 (xx)
DK (1) DK159435C (xx)
ES (1) ES490667A0 (xx)
FR (1) FR2455590A1 (xx)
GB (1) GB2053897B (xx)
IE (1) IE49549B1 (xx)
IL (1) IL59596A (xx)
IT (1) IT1143190B (xx)
NL (1) NL8002071A (xx)
NO (1) NO152698C (xx)
NZ (1) NZ193107A (xx)
PH (1) PH17089A (xx)
SE (1) SE447109B (xx)
ZA (1) ZA801453B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3400168A1 (de) * 1984-01-04 1985-07-11 Bayer Ag, 5090 Leverkusen 5-halogenalkyl-1,3,4-thiadiazol-2-yloxyacetamide
US4616017A (en) * 1984-06-04 1986-10-07 Merck & Co., Inc. Aminohydroxypropoxy substituted aryl compounds
DE3505425A1 (de) * 1985-02-16 1986-08-21 Bayer Ag, 5090 Leverkusen 5-chlor-1,3,4-thiadiazol-2-yloxy-acetamide
GB8603120D0 (en) * 1986-02-07 1986-03-12 Pfizer Ltd Anti-dysrhythmia agents
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
US4956302A (en) * 1987-09-11 1990-09-11 Abbott Laboratories Lateral flow chromatographic binding assay device
DE3812755A1 (de) * 1988-04-16 1989-10-26 Merck Patent Gmbh Salicylsaeurederivate
KR100484386B1 (ko) * 2000-10-04 2005-04-22 경동제약 주식회사 알킬2-[2,3,5-트리플루오로-4-(4-메틸-1-피페라지닐)]벤조일-3(s)-(1-히드록시프로피-2-닐아미노)아크릴레이트의 제조방법
US20080131954A1 (en) * 2006-11-30 2008-06-05 Canon U.S. Life Sciences, Inc. Method of Separating Target DNA from Mixed DNA

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1317479A (en) * 1970-11-10 1973-05-16 Pfizer Ltd 1-2-hydroxy-3-phenoxy or phenylthiopropyl-4-phenyl-piperazine derivatives
US4038279A (en) * 1972-12-23 1977-07-26 Boehringer Ingelheim Gmbh N-aryl-n'-(phenyl-or phenoxy-alkyl)-piperazines and salts thereof
CA1113937A (en) * 1977-04-05 1981-12-08 Frederic P. Hauck Substituted piperidinylpropanols

Also Published As

Publication number Publication date
ES8104995A1 (es) 1981-05-16
NO152698C (no) 1985-11-20
DE3014813A1 (de) 1980-11-13
FR2455590A1 (fr) 1980-11-28
PH17089A (en) 1984-05-29
NO152698B (no) 1985-07-29
GB2053897B (en) 1982-10-20
IL59596A0 (en) 1980-06-30
CH645368A5 (de) 1984-09-28
IT1143190B (it) 1986-10-22
ZA801453B (en) 1980-12-31
JPS55147262A (en) 1980-11-17
US4255575A (en) 1981-03-10
DK159435C (da) 1991-03-25
DK193680A (da) 1980-11-05
NZ193107A (en) 1982-12-21
AU531738B2 (en) 1983-09-01
DK159435B (da) 1990-10-15
IE800481L (en) 1980-11-04
IE49549B1 (en) 1985-10-30
ATA232580A (de) 1984-04-15
CA1138457A (en) 1982-12-28
IL59596A (en) 1984-01-31
AU5707680A (en) 1980-11-06
GB2053897A (en) 1981-02-11
JPS6321666B2 (xx) 1988-05-09
IT8048267A0 (it) 1980-03-26
FR2455590B1 (xx) 1983-10-14
BE883086A (fr) 1980-09-01
NL8002071A (nl) 1980-11-06
SE447109B (sv) 1986-10-27
SE8003244L (sv) 1980-11-05
ES490667A0 (es) 1981-05-16
NO801297L (no) 1980-11-05

Similar Documents

Publication Publication Date Title
AT376207B (de) Verfahren zum herstellen von neuen piperidinderivaten und deren saeureadditionssalzen
AT376208B (de) Verfahren zum herstellen von neuen piperidinderivaten und deren salzen
AT376432B (de) Verfahren zum herstellen von neuen carbostyrilderivaten und von deren saeureadditions-salzen
AT367038B (de) Verfahren zum herstellen neuer carbostyrilderivate
AT372381B (de) Verfahren zum herstellen von loeslichen salzen des (+)-catechins
AT375349B (de) Verfahren zum herstellen neuer 4-aroylimidazol-2- one und ihrer salze
AT364835B (de) Verfahren zur herstellung neuer 0-substituierter derivate des (+)-cyanidan-3-ols und ihrer salze
AT376972B (de) Verfahren zum herstellen neuer carbostyrilderivate und von saeureadditionssalzen und quaternaeren salzen hievon und ihren optischen isomeren
AT355206B (de) Verfahren zum herstellen von neuen derivaten der 7-acylamido-3-cephem-4-carbonsaeure und ihren salzen
ATA690076A (de) Magnetkopf und verfahren zum herstellen eines solchen magnetkopfes
AT374458B (de) Verfahren zum herstellen von neuen piperidinderivaten und deren salzen
AT376426B (de) Verfahren zum herstellen neuer derivate der 2-hydroxy-5-(1-hydroxy-2-piperazinylaethyl)benzoes[ure und saeureadditionssalzen hievon
AT376210B (de) Verfahren zum herstellen von neuen benzimidazolderivaten und von estern und salzen hievon
AT358036B (de) Verfahren zur herstellung neuer derivate des m- -trifluormethylphenylpiperidins und ihrer salze
AT370095B (de) Verfahren zum herstellen von neuen 1-aryl-alkyl-imidazolderivaten und deren salzen
ATA909480A (de) Verfahren zum herstellen von neuen carbostyrilderivaten und ihren salzen
AT374196B (de) Verfahren zur herstellung neuer derivate des tetrahydropyridin-4-yl indols und ihrer salze
ATA497478A (de) Verfahren zum herstellen neuer benzamidin- derivate
AT365578B (de) Verfahren zur herstellung neuer derivate der 2((4-chinolinyl)amino)-5-fluorbenzoesaeure und ihrersalze
ATA783078A (de) Verfahren zur hertellung neuer derivate des eburnamenins
ATA68884A (de) Verfahren zum herstellen neuer carbostyrilderivate und von saeureadditionssalzen und quaternaeren salzen hievon und ihren optischen isomeren
AT355211B (de) Verfahren zum herstellen von neuen derivaten der 7-acylamido-3-cephem-4-carbonsaeure und ihren salzen
AT356089B (de) Verfahren zur herstellung neuer derivate der 4-cyclohexyl-1-naphthalinessigsaeure
AT374797B (de) Verfahren zum herstellen neuer phenolester sowie ihren salzen
ATA507181A (de) Verfahren zum herstellen von neuen 1-arylalkyl-imidazolderivaten und deren salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee